Bristol-Myers Squibb | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 3.73B 5.22B 2025-03
Abbott USD 1.66B 253M 2025-03
ALKERMES USD 162.69M 57.93M 2024-12
Amgen USD 2.31B 182M 2024-12
AstraZeneca USD 3.67B 1.64B 2025-03
Biogen USD 441.4M 24.4M 2024-12
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Drreddys Laboratories INR 18.72B 1.17B 2024-12
Eli Lilly USD 5.41B 259.6M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
J&J USD 13.63B 9.74B 2025-03
Medtronic USD 1.65B 51M 2025-01
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novo Nordisk 33.82B 7.89B 2024-09
Perrigo USD 112.7M 37.4M 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Prestige Brands USD 91.96M 7.62M 2024-12
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
Sanofi EUR 861M 2.77B 2024-12
United Therapeutics USD 382.8M 25.1M 2025-03
Zoetis USD 732M 142M 2024-12



Bristol-Myers Squibb L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.